“ Fluvastatin therapy inhibited the susceptibility of LDL to copper ion –induced oxidation, as shown by prolongation of the lag time by 22% and by a reduction of thiobarbituric acid–reactive substances (TBARS) levels by 14%, as compared with the patient's LDL baseline oxidation.”